Evidence of gene amplification in the form of double minute chromosomes is frequently observed in lung cancer
- PMID: 8384074
- DOI: 10.1016/0165-4608(93)90219-c
Evidence of gene amplification in the form of double minute chromosomes is frequently observed in lung cancer
Abstract
Amplification of cellular proto-oncogenes, important in tumor progression, has been correlated with a poor clinical outcome in a variety of human tumor types. Amplified genes are observed in two cytogenetically distinct entities, double minutes (DMs) and homogeneously staining regions (HSR). We examined 54 fresh lung tumor specimens obtained from patients with non-small cell lung cancer for cytogenetic evidence of gene amplification in the form of DMs. The majority of these patients had received no prior treatment. The cells were harvested within 24 hours after receiving the specimens, and the slides were stained with Giemsa to specifically look for DMs. We found DMs in 24 of 31 (77%) specimens that exhibited metaphase spreads. Similar incidences of DMs were found when histologic cell types, primary vs. non-primary tumors, and specimens from patients with prior treatment vs. no prior treatment were compared. Therefore, DMs occur frequently in non cultured lung tumor cells, providing evidence that gene amplification may be an important aspect of tumor behavior in patients with non-small cell lung carcinoma. Further investigation is warranted to identify the specific tumor-related genes located on these abnormal chromosomes. This also suggests that ongoing efforts to eliminate amplified drug-resistant genes or oncogenes contained on DMs in tumor cells may be relevant in patients with non-small cell lung cancer.
Similar articles
-
Double minute chromosomes and homogeneously staining regions in tumors taken directly from patients versus in human tumor cell lines.Anticancer Drugs. 1991 Feb;2(1):11-25. doi: 10.1097/00001813-199102000-00002. Anticancer Drugs. 1991. PMID: 1720337 Review.
-
Chromosome alterations in 21 non-small cell lung carcinomas.Genes Chromosomes Cancer. 1990 Nov;2(4):328-38. doi: 10.1002/gcc.2870020411. Genes Chromosomes Cancer. 1990. PMID: 2176544
-
Chromosome abnormalities in human non-small cell lung cancer.Cancer Res. 1992 May 1;52(9 Suppl):2702s-2706s. Cancer Res. 1992. PMID: 1314134
-
Chromosome alterations in human small cell lung cancer: frequent involvement of 5q.Cancer Res. 1992 Mar 1;52(5):1322-8. Cancer Res. 1992. PMID: 1346589
-
Gene amplification in human lung cancer. The myc family genes and other proto-oncogenes and growth factor genes.Am Rev Respir Dis. 1990 Dec;142(6 Pt 2):S20-6. doi: 10.1164/ajrccm/142.6_Pt_2.S20. Am Rev Respir Dis. 1990. PMID: 2174659 Review.
Cited by
-
Extrachromosomal driver mutations in glioblastoma and low-grade glioma.Nat Commun. 2014 Dec 4;5:5690. doi: 10.1038/ncomms6690. Nat Commun. 2014. PMID: 25471132 Free PMC article.
-
Hprt mutants in a transplantable murine tumour arise more frequently in vivo than in vitro.Br J Cancer. 1995 Nov;72(5):1234-40. doi: 10.1038/bjc.1995.492. Br J Cancer. 1995. PMID: 7577474 Free PMC article.
-
Different Facets of Copy Number Changes: Permanent, Transient, and Adaptive.Mol Cell Biol. 2016 Jan 11;36(7):1050-63. doi: 10.1128/MCB.00652-15. Mol Cell Biol. 2016. PMID: 26755558 Free PMC article. Review.
-
Extrachromosomal Circular DNA: A New Target in Cancer.Front Oncol. 2022 Apr 14;12:814504. doi: 10.3389/fonc.2022.814504. eCollection 2022. Front Oncol. 2022. PMID: 35494014 Free PMC article. Review.
-
Allele-specific copy number analysis of tumor samples with aneuploidy and tumor heterogeneity.Genome Biol. 2011 Oct 24;12(10):R108. doi: 10.1186/gb-2011-12-10-r108. Genome Biol. 2011. PMID: 22023820 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical